3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Colorectal Neoplasms
23
Rectal Neoplasms
11
Colonic Neoplasms
11
Pancreatic Neoplasms
9
Stomach Neoplasms
8
Esophageal Neoplasms
8
Adenocarcinoma Of Esophagus
8
Cholangiocarcinoma
6
Adenocarcinoma
6
Neoplasm Metastasis
5
Lymphoma, Large B-Cell, Diffuse
5
Parkinson Disease 4, Autosomal Dominant Lewy Body
4
Ovarian Neoplasms
3
Neoplasms
3
Gallbladder Neoplasms
3
Endometrial Neoplasms
3
Carcinoma, Non-Small-Cell Lung
3
Carcinoma, Hepatocellular
3
Biliary Tract Neoplasms
3
Recurrence
2
Lymphoma, Non-Hodgkin
2
Lymphoma, Follicular
2
Lung Neoplasms
2
Fallopian Tube Neoplasms
2
Esophageal Squamous Cell Carcinoma
2
Carcinoma
2
Triple Negative Breast Neoplasms
1
Thyroid Neoplasms
1
Solid Tumors
1
Small Bowel Adenocarcinoma
1
Interventions
Platinum
3
Pemetrexed
3
Cisplatin
3
1,2-diaminocyclohexaneplatinum II citrate
3
pembrolizumab
2
Radiotherapy
2
Radiation
2
cediranib
1
atezolizumab
1
Radiotherapy, Intensity-Modulated
1
Pharmacogenomic Testing
1
Combined Modality Therapy
1
Cerebral Decortication
1
Carboplatin
1
Brentuximab Vedotin
1
Blood Component Removal
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Mesothelioma, Malignant
×
Oxaliplatin
×
30 days
×
Clear all
No trials found.